Law Firm Probes Option Care Health Shareholder Rights (OPCH)
Monteverde & Associates is investigating Option Care Health over potential shareholder concerns, the M&A-focused class action firm announced.
A New York-based securities law firm has launched an investigation into Option Care Health, Inc., the home and alternate-site infusion therapy company traded on the Nasdaq under the ticker OPCH, according to an announcement released Thursday.
Monteverde & Associates PC, whose lead attorney Juan Monteverde specializes in merger-and-acquisition class action litigation, is examining whether Option Care Health shareholders may have claims related to the company. The firm describes itself as having recovered millions of dollars for investors in prior actions and was listed among the top 50 firms in the 2025 ISS Securities Class Action Services Report.
Read more Law Firm Probes Pacira BioSciences Over Shareholder Rights →
Shareholder investigations of this type typically precede a formal lawsuit and are often triggered by announced mergers, acquisitions, or other corporate transactions that attorneys believe may undervalue a company's stock or disadvantage retail and institutional investors. The precise transaction or conduct under scrutiny in the Option Care Health probe was not detailed in the announcement.
Option Care Health is one of the largest independent providers of home infusion services in the United States, making it a notable target for legal scrutiny whenever significant corporate activity occurs. Shareholders who held OPCH stock and believe they may have been harmed are generally encouraged by such firms to contact counsel before any legal deadlines.
Continue reading at All Financial Services & Investing.
